期刊文献+

糖尿病患者血尿酸、血脂水平变化与肾损害的关系

The Correlations of UA and Lipid Levels with Renal Damage in Diabetics
下载PDF
导出
摘要 目的探讨糖尿病患者血尿酸、血脂水平变化与肾损害的关系。方法 2009年2月至2013年12月我院肾内科及内分泌科收治的单纯糖尿病患者40例作为观察组,同期选择收治的糖尿病肾病但肾功能正常患者40例作为对照组,检测所有患者血尿酸、血脂水平。结果观察组患者的血尿酸值(212.55±28.27)μmol/L明显低于对照组(352.23±34.21)μmol/L(P<0.05),且都处在非正常范围内。观察组的TG、TC和LDL-C值明显低于对照组,而HDL-C值明显高于对照组,对比差异都有统计学意义(P<0.05)。结论糖尿病患者血尿酸随肾损害的加重而升高,血脂水平的异常,要积极进行监测与干预。 Objective To explore the correlations of UA and lipid levels with renal damage in diabetics. Methods From February 2009 to December 2013, 40 cases of diabetics in our hospital of renal medicine and endocrinology department were chosen as treatment group. 40 cases of DN patients with normal renal function in corresponding period were as control. The UA and lipid levels were detected. Results The UA of treatment group(212.55±28.27)μmol/L were significantly lower than control(352.23±34.21)μmol/L(P〈0.05) in abnormal range. TG, TC and LDL-C level were lower than control, yet HDL-C level were higher than control(P〈0.05). Conclusions UA level in diabetics increases following the development of renal damage with abnormal lipid levels, need positive monitoring and intervention.
出处 《中国医药指南》 2015年第10期32-33,共2页 Guide of China Medicine
关键词 糖尿病 血尿酸 血脂 肾损害 Aiabetic UA Lipid level Renal damage
  • 相关文献

参考文献7

二级参考文献26

  • 1Elekelles RS,Diamond JR,Poulter C,et al.Cardiovascular outcome in type 2 diabetes: a double-blind placebo-controlled study of bezafibrate: the St.Marys, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) study[].Diabetes Care.1998
  • 2Goldberg RB,Mellies MJ,Sacks FM,et al.Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels:subgroup analyses in the cholesterol and recurrent events (CARE)trail.The Care Investigators[].Circulation.1998
  • 3Howard BV,Robbins DC,Sievers ML,et al.LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the strong heart study[].Arteriosclerosis and Thrombosis.2000
  • 4Lamarche B,Tchernof A,Mauriege P,et al.Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease[].The Journal of The American Medical Association.1998
  • 5Grover SA,Coupal L,Zowall H,et al.Cost-effectiveness of treating hyperlipidemia in the presence of diabetes: who should be treated[].Circulation.2000
  • 6Turner RC,Millns H,Neil HA,et al.Risk factors for coronary artery disease in non-insulin-dependent diabetes mellitus (UKPDS:23)[].British Medical Journal.1998
  • 7Steiner G,Stewazt D,Horsking JD.Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study(DAIS).World Health Organization Collaborating Centre for the Study of Atherosclerosis in Diabetes[].The American Journal of Cardiology.1999
  • 8ADA.Nutrition recommendation and principles for people with diabetic mellitus ( Position statement)[].Diabetes Care.1998
  • 9Scandinavian Simvostatin Survival Study Group.Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study ( 4S)[].The Lancet.1994
  • 10Laakso M,Lehto S,Penttila I,et al.Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes[].Circulation.1993

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部